Paramount Skydance rilis transkrip paparan kinerja kuartal II 2026
Reuters2026/08/11 20:58- Paramount Skydance merilis transkrip paparan kinerja kuartal II 2026; hadir CEO David Ellison, CFO Dennis K. Cinelli, CSO/COO Andrew BrandonGordon.
- Ellison menegaskan keyakinan transaksi dengan Warner Bros. Discovery akan selesai; izin diterima dari 65 yurisdiksi, sidang ditetapkan Maret tahun depan.
- Cinelli memperkirakan biaya tambahan jika penutupan molor: fee bridge USD 8-9 juta per bulan; ticking fee USD 0,25 per saham per kuartal.
- Paramount+ naik ke 81,6 juta pelanggan; pendapatan naik 16%, ditopang kenaikan ARPU, retensi terbaik, jam tonton naik dua digit.
- Perusahaan menaikkan panduan EBITDA disesuaikan 2026 menjadi USD 3,8-3,9 miliar; konversi arus kas bebas minimal 10%, proyeksi pendapatan tetap USD 30 miliar.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
